2019 Expert opinion on biological treatment use in inflammatory bowel disease management

dc.authoridYILDIRIM, Süleyman/0000-0002-2607-6738
dc.authoridDağlı, Ülkü/0000-0003-0664-0976;
dc.authorwosidAKPINAR, HALE/Q-2507-2019
dc.authorwosidakyuz, filiz/AAS-8397-2020
dc.authorwosidÇELİK, AYKUT FERHAT/AAB-4652-2021
dc.authorwosidYILDIRIM, Süleyman/HIK-2890-2022
dc.authorwosidDağlı, Ülkü/S-4068-2018
dc.authorwosidTörüner, Murat/AAQ-1826-2020
dc.contributor.authorToruner, Murat
dc.contributor.authorAkpinar, Hale
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorDagli, Ulku
dc.contributor.authorHamzaoglu, Hulya Over
dc.contributor.authorTezel, Ahmet
dc.contributor.authorUnsal, Belkis
dc.date.accessioned2024-06-12T11:18:51Z
dc.date.available2024-06-12T11:18:51Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipTakeda Turkeyen_US
dc.description.sponsorshipThe authors declared that this study was supported by Takeda Turkey with an unconditional educational grant.en_US
dc.identifier.doi10.5152/tjg.2019.061119
dc.identifier.endpageS946en_US
dc.identifier.issn2148-5607
dc.identifier.pmid32207688en_US
dc.identifier.scopus2-s2.0-85079904412en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageS913en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2019.061119
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24986
dc.identifier.volume30en_US
dc.identifier.wosWOS:000504427700001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal Of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEvidence-Based Consensusen_US
dc.subjectSevere Ulcerative-Colitisen_US
dc.subjectTumor-Necrosis-Factoren_US
dc.subjectAnti-Tnf Therapyen_US
dc.subjectActive Crohns-Diseaseen_US
dc.subjectMaintenance Therapyen_US
dc.subjectDouble-Blinden_US
dc.subject5-Aminosalicylic Aciden_US
dc.subjectControlled-Trialen_US
dc.subjectHepatitis-Ben_US
dc.title2019 Expert opinion on biological treatment use in inflammatory bowel disease managementen_US
dc.typeArticleen_US

Dosyalar